First Trust Health Care Alphadex
ALTAR
Score™
7.0% info Recommen-
dation
OVERWEIGHT
2019E    2020E
P/E
ratio
17.6x P/Sales
ratio
1.0x
P/BV
ratio
3.2x Div.
yield
0.6%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
First Trust Health Care AlphaDEX Fund seeks investment results that correspond to the StrataQuant Health Care AlphaDEX Index.

FUND BASICS
Category US Equities
Fund Sponsor First Trust Advisors LP
Website www.ftportfolios.com
Inception date May 10, 2007
Assets (mns) $1,160
Currency USD
Expense ratio 63 bp
Distributions Quarterly

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian Bank of New York Mellon
Weighting Tiered
Index replication Full
Uses derivatives No
Options available Yes

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 79
Wgt avg mkt cap (mns) $43,269
Large cap (>$10bn) 76.0%
Mid cap ($2-10bn) 24.0%
Small cap (<$2bn) 0.0%
Developed mkts 100.0%
Emerging mkts 0.0%

TOP TEN HOLDINGS
SEATTLE GENETICS INC 2.7 %
BIOGEN IDEC INC 2.5 %
MOLINA HEALTHCARE INC 2.4 %
HORIZON PHARMA PLC 2.3 %
JAZZ PHARMACEUTICALS PLC 2.3 %
ALEXION PHARMACEUTICALS INC 2.3 %
MEDNAX INC 2.3 %
DEXCOM INC 2.2 %
BIO-RAD LABORATORIES-CL A 2.2 %
INSULET CORP 2.2 %
Total 23.5 %

TOP COUNTRY EXPOSURE
UNITED STATES 89.7 %
IRELAND 6.1 %
BRITAIN 1.9 %
NETHERLANDS 0.9 %







HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru November 30)
Year-to-date 1 year 5 years 10 years Since Incep.
20.6% 6.2% 6.6% 15.1% 12.3%

Market Correlations
versus... Beta R-squared
S&P500 1.12 73%
MSCI EAFE 0.89 39%
MSCI Emg. Mkts. 0.64 32%

Technical Indicators
Recent close $83.42
30d moving avg. $79.73
Annualized volatility 15.8%
Short interest (ETF) 1.8%
Short interest (Underlying) 4.6%
Relative strength (RSI) 76

Liquidity measures
Avg. volume (thou.) 84
Turnover 0.6%
Bid/Ask (% of price) 0.06%
ADV underlying (mns) $18,701

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the First Trust Health Care Alphadex ETF based on the alternatives' overlap in portfolio holdings with FXH. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: FXH Expense: 63 bp ALTAR Score™: 7.0%


ALTERNATIVE ETFs BASED ON OVERLAP WITH FXH
Ticker Fund
Name
Overlap1
vs FXH
(%)
Expense
ratio
(bp)
Savings
vs FXH
(bp)
ALTAR
Score™
(%)
ALTAR
vs FXH
(%)
RYH Invesco S&P Equal Weight Healthcare 58.9 40 23 7.0 -0.0
JHMH John Hancock Multifactor Health Care 55.8 40 23 6.6 -0.4
FHLC Fidelity MSCI Health Care 41.1 8 55 5.7 -1.3
VHT Vanguard Health Care 41.0 10 53 5.9 -1.1
IYH iShares US Healthcare 40.9 43 20 6.2 -0.8
XLV Health Care Select Sector SPDR 38.8 13 50 7.2 +0.2
IEHS iShares Evolved U.S. Healthcare Staples 36.3 18 45 5.9 -1.1
IXJ iShares S&P Global Healthcare 32.2 46 17 6.3 -0.7
XHS SPDR S&P Health Care Services 29.6 35 28 6.0 -1.0
IEIH iShares Evolved U.S. Innovative Healthcare 27.2 18 45 4.4 -2.6
GDNA Goldman Sachs Motif Human Evolution 24.6 50 13 1.0 -6.0
PJP Invesco Dynamic Pharmaceuticals 24.0 56 7 9.3 +2.3
PBE Invesco Dynamic Biotechnology & Genome 24.0 57 6 -0.5 -7.5
XHE SPDR S&P Health Care Equipment 23.2 35 28 2.1 -4.9
IHI iShares DJ US Medical Devices 22.9 43 20 3.8 -3.2
HTEC Robo Global Healthcare Technology and Innovation 22.8 68 -5 -0.1 -7.0
LNGR Global X Longevity Thematic 21.9 50 13 3.3 -3.7
IHF iShares US Healthcare Providers 21.9 43 20 7.3 +0.3
PTH Invesco DWA Healthcare Momentum 21.1 60 3 -1.2 -8.2
FBT First Trust NYSE-ARCA Biotechnology 19.6 57 6 -0.7 -7.7

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
First Trust Health Care Alphadex
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

OVERWEIGHT

Above average appreciation potential. A rating of OVERWEIGHT is assigned to ETFs with ALTAR Scores in the 4th quintile (ranking higher than 60%-80%) of their category. Typically, funds in this category consist of stocks trading at attractive valuations and/or having above-average fundamentals.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 20.8 %
Divided by: Fwd. P/BV 2.7 x
Less: Expense ratio 63 bp
Equals: ALTAR Score 7.0 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.45 CATEGORY
AVERAGE
1.56
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.